Cytocell® FISH Probes
High-quality range of FISH probes for the detection of gene rearrangements related to inherited genetic disease and cancer.
Find out more
For more information about any OGT product or service, please contact us.
Overview
High quality, directly labelled DNA probes for fluorescence in situ hybridisation (FISH).
Cytocell Global Website
If you are based outside North America please go to our global website at www.cytocell.com where you can:
Cytocell North American Website
If you are based in North America please go to our North American website at www.cytocell-us.com where you can:
Resources
Brochure
-
An integrated approach to profiling haematological disorders
For accurate detection of all types of genetic aberrations, various technologies are used. View OGT's integrated portfolio of products that allow the accurate analysis of haematological disorders.
-
An integrated approach to tumour profiling
Various technologies are available to study the mutations that cause cancer, but none is capable of accurate detection of all types of genetic aberrations. View OGT's integrated portfolio of products that allow the accurate analysis of solid tumours.
-
Integrated solutions for the genomic study of inherited disease
Our class-leading products are designed for the robust identification of the whole range of genomic variation, with an emphasis on custom solutions to target the regions important for your research.
Product profile
Article
-
Q&A with Dr. Theresa C. Brown, Tulane University School of Medicine.
-
Under the Microscope: Megumi Hada, PhD, Senior Research Scientist, RaISE, Prairie View, Texas A&M
Catalogue
-
OGT Product Catalog - USA and Canada
Including Cytocell® FISH probes for Constitutional Cytogenetics and Hematology/Pathology Cytogenetics, CytoSure™ NGS and Array Products for Cytogenetics and Rare Disease Research and SureSeq™ NGS Products for Hematology and Solid Tumor Cancer Research.
-
OGT Product Catalogue
Including Cytocell® FISH Probes for Cancer and Inherited Genetic Disease, CytoSure™ NGS and Array Products for Cytogenetics and Rare Disease, and SureSeq™ NGS Products for Haematology and Solid Tumour Cancers.